Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Arjuna Unveils New Botanical Analgesic Blend


News provided by

Arjuna Natural Ltd.

19 Aug, 2020, 11:00 GMT

Share this article

Share toX

Share this article

Share toX

Proprietary SPEED™ technology delivers fast pain relief safely as demonstrated in new clinical study

KOCHI, India, Aug. 19, 2020 /PRNewswire/ -- Arjuna Natural pioneers a holistic approach to fast pain alleviation with its launch of Rhuleave-K®, a proprietary botanical formula clinically supported to bestow safe pain relief at an efficacy and speed comparable to popular OTC drugs, such as acetaminophen (paracetamol).

Continue Reading
This image opens in the lightbox
Arjuna Unveils New Botanical Analgesic Blend

Rhuleave-K is a high-dissolution liquid composition comprising turmeric (Curcuma longa) and frankincense (resinous extract of Boswellia serrata), combined in a black sesame oil base. The three botanicals are synergistically blended with a unique proprietary technology to provide fast relief of acute musculoskeletal pain.

"There are a number of herbal extracts and formulations in the market that target pain and inflammation, but they are slow-acting and typically provide relief over a period of weeks," explains Benny Antony, PhD, Joint Managing Director for Arjuna. "We found very limited clinical data on efficacy of herbal products for acute pain relief which is what spurred the development of this unique formula."

Curcumin is one of the most extensively studied natural compounds, especially for relieving pain and inflammation. It has demonstrated ability to exert a broad spectrum of biological activity for modulating inflammatory signaling pathways.

The analgesic activity of B. serrata extract also has been identified in several studies, particularly its positive effect on joint tenderness in cases of osteoarthritis. It, too, has exhibited abilities to raise the pain threshold in comparison to placebos. These two ingredients can work together to block various channels of pain, specifically COX-2 (cyclooxygenase) and LOX (lipoxygenase) receptors.

Arjuna's key to fast action

The company applies a novel SPEEDTM delivery technology that ensures the swift, uniform dispersal of the actives, thereby facilitating its fast-action mechanism. Black sesame oil acts not only as an effective carrier, helping to disperse and dissolve fat-soluble compounds into the body, but in traditional Ayurvedic practice sesame oil is touted for its warming, penetrative, and anti-inflammatory properties. Recorded recognition of sesame as both a food and a medicine goes back thousands of years to ancient Assyrian times.

Clinically backed natural pain-relief

Rhuleave K's superior analgesic activity was demonstrated in a randomized, active, controlled, open-label study led by Girish Rudrappa, PhD, at the Sapthagiri Institute of Medical Sciences and Research Center in Bangalore, India and published in the Journal Medicine, April 2020.

The study involved 88 healthy subjects with acute musculoskeletal pain. They were randomized to receive 1,000mg per day of Rhuleave-K or 1,000mg of acetaminophen. Results revealed a positive response of pain relief (analgesia) comparable to acetaminophen, without risks of side effects or interactions with other medicines. Onset of analgesia was experienced in about 1 hour following administration. Earliest pain relief could be seen as early as 2.4 hours comparable with the paracetamol.

Results of the study also showed significant reduction in pain, irrespective of intensity, on a similar level to acetaminophen. Rhuleave-K was equally effective as acetaminophen in reducing the sensory pain but was superior to the drug in reducing the emotional side effects of pain. Moreover, Rhuleave-K's curcumin component has demonstrated significant anti-inflammatory capacity. Toxicity studies show that Rhuleave-K is safe, even in doses 11 times the recommended daily dosage.

"Rhuleave-K is a breakthrough pain-support formula," enthuses Antony. "It's the first  natural alternative to OTC meds that is able to provide meaningful relief in a short amount of time, and effectively targets most types of musculoskeletal pain, such as lower back pain , sprains, tendonitis, and joint pain. Its zero toxicity qualities means it can be safely used by nearly all consumers and all ages."

The curcumin and sesame oil ingredients are sourced from partner farmers under a rigorous process that ensures purity and efficacy. Boswellia serrata is wild-crafted, sustainably providing employment and boosting livelihoods to many marginal communities in India. The liquid, fat-soluble formula can be readily integrated into soft gels, liquid capsules, or syrups.

About Arjuna Natural

For more than a quarter of a century Arjuna Natural (Arjuna Natural Pvt., Ltd.) has been India's leading manufacturer of standardized spice and botanical extracts for food supplement industries dedicated firmly to ecofriendly and sustainable practices. Established in 1992, the company has grown rapidly, with customers in 64 countries and has an advanced research facility that works in collaboration with international universities on phytochemistry, pharmacokinetics, formulation, development, pre-clinical and toxicity studies. Arjuna Natural's facilities comply with the highest world standards, are GMP-certified, and have ISO, Star-K kosher, and halal certifications. The company is committed to social responsibility and employee welfare and has recently partnered with Eurofins, a World leader in food, environment, pharma product testing & agroscience CRO services to conduct regular checks of vulnerable surfaces across the company for possible Corona Virus  presence.

For further information, please contact:

Company contact

Benny Antony, PhD

Joint Managing Director

Email: benny@arjunanatural.com

Website: www.arjunanatural.com

Twitter: @ArjunaExtracts 

 

Press Contact

NutriPR

Liat Simha

Tel: +972-9-9742893

E-mail: liat@nutripr.com

Website: www.nutripr.com 

Twitter: @LiatSimha 

Photo: https://mma.prnewswire.com/media/1230529/Arjuna_Rhuleave.jpg 

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.